Journal article icon

Journal article

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.

Abstract:

BACKGROUND AND OBJECTIVE: Two long-acting depot somatostatin analogues have recently been licensed for the treatment of acromegaly. We wished to assess the effectiveness of both these drugs in suppressing mean GH to a target of < 5 mU/l in patients with acromegaly unselected for responsiveness to octreotide, and also to compare the effects of both drugs METHODS: We prospectively studied 10 unselected patients with acromegaly who were treated first with lanreotide (LAN) and then octreotide ...

Expand abstract

Actions


Access Document


Authors


Journal:
Clinical endocrinology
Volume:
51
Issue:
3
Pages:
275-280
Publication date:
1999-09-05
DOI:
EISSN:
1365-2265
ISSN:
0300-0664
URN:
uuid:fc568980-978a-4e96-bf4e-c21d48b74404
Source identifiers:
8541
Local pid:
pubs:8541

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP